217 related articles for article (PubMed ID: 34232067)
1. Performance of the sōna
Jani K; McMillen T; Morjaria S; Babady NE
J Clin Microbiol; 2021 Aug; 59(9):e0059821. PubMed ID: 34232067
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
[TBL] [Abstract][Full Text] [Related]
4. Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Hoenigl M; Egger M; Boyer J; Schulz E; Prattes J; Jenks JD
Mycoses; 2021 Oct; 64(10):1197-1202. PubMed ID: 34252244
[TBL] [Abstract][Full Text] [Related]
5. An Evaluation of the Performance of the IMMY
White PL; Price JS; Posso R; Vale L; Backx M
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32967903
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Performance of the IMMY sona
White PL; Price JS; Posso R; Cutlan-Vaughan M; Vale L; Backx M
J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32188687
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different lateral flow assays on bronchoalveolar lavage fluid for invasive aspergillosis screening in non-hematological patients.
Devillers E; Scherer E; Navellou JC; Grenouillet F; Millon L; Bellanger AP
J Mycol Med; 2024 Jun; 34(2):101481. PubMed ID: 38718721
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two-centre study.
Scharmann U; Verhasselt HL; Kirchhoff L; Buer J; Rath PM; Steinmann J; Ziegler K
Mycoses; 2020 Dec; 63(12):1362-1367. PubMed ID: 32885514
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study.
Jenks JD; Prattes J; Frank J; Spiess B; Mehta SR; Boch T; Buchheidt D; Hoenigl M
Clin Infect Dis; 2021 Oct; 73(7):e1737-e1744. PubMed ID: 32866234
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
12. Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid.
Aerts R; Mercier T; Houben E; Schauwvlieghe A; Lagrou K; Maertens J
J Clin Microbiol; 2022 Nov; 60(11):e0094822. PubMed ID: 36214562
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the EUROIMMUN Aspergillus antigen immunoenzyme assay in serum and bronchoalveolar lavage fluid samples.
Roiz-Mesones MP; Pintos-Fonseca AM; Ahedo-García N; Alegría-Puig CR
Enferm Infecc Microbiol Clin (Engl Ed); 2023 Mar; 41(3):176-180. PubMed ID: 36870734
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Aspergillus galactomannan lateral flow assay with a digital reader for the diagnosis of invasive aspergillosis: a multicenter study.
Guo J; Xiao C; Tian W; Lv L; Hu L; Ni L; Wang D; Li W; Qiao D; Wu W
Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):249-257. PubMed ID: 38030860
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
18. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
Serin I; Dogu MH
Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the JF5-based Aspergillus galactomannoprotein lateral flow device for diagnosing invasive aspergillosis in cancer patients.
Wan L; Cai X; Ling M; Kan J; Yin M; Wang H
Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1221-1229. PubMed ID: 38625450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
